Summary
Eszopiclone is a Schedule IV controlled substance in the United States. Tolerance develops rapidly within a couple of weeks of daily use. Abrupt cessation after prolonged use can cause severe withdrawal symptoms; gradual tapering or cross-over to long-acting benzodiazepines like diazepam is recommended. Should not be taken with or immediately after high-fat meals as this delays absorption. Users should avoid driving or operating machinery the next day due to potential next-day impairment.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 1-1.5mg | 2-3mg | 4-5mg | 6mg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Peak | Offset | After Effects | Total |
|---|---|---|---|---|---|
| Oral | 10-20 min | 30-90 min | 3-5 hrs | 24 hrs | 360-0 min |
Tolerance
Build-up
develops over 1–4 weeks of regular use
Reset
days to weeks depending on duration of use
Effects
Positive
- Muscle Relaxation
- Anxiolytic
- Muscle relaxant
- Muscle relaxation
Negative
- Respiratory Depression
- Sedation
- Sedative
- Dystaxia
- Hypnotic
- Sleep induction
Positive
- Anxiety Suppression
- Euphoria
Negative
- Dizziness
- Motor Control Loss
- Amnesia
- Emotion Suppression
- Thought Deceleration
- Analysis Suppression
- Delirium
- Delusion
- Irritability
- Compulsive Redosing
- Time Compression
- Shadow People
Positive
- Tracers
- Increased Music Appreciation
Negative
- Disinhibition
- Acuity Suppression
- Metallic Taste
- Visual Drifting
- External Hallucinations
- Auditory Hallucinations
- Gustatory hallucination
- Visual drifting